2932.99.61 | 00 | Other: | | | | |
2932.99.70 | 00 | Other | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P) 0.2¢/kg + 3.1% (SG) | 15.4¢/kg + 52% |
2932.99.90 | | Other | | 3.7% | Free (A*,AU,BH, CA,CL,E,IL,J,JO, K,MA,MX, P,SG) | 25% |
2932.99.90 | 90 | Other | kg | | | |
2933.11.00 | 00 | Compounds containing an unfused pyrazole ring (whether or not hydrogenated) in the structure: | | | | |
2933.19 | | Other: | | | | |
2933.19.23 | 00 | Other: | | | | |
2933.19.30 | 90 | Other | kg | | | |
2933.19.37 | 00 | Other: | | | | |
2933.19.43 | 00 | Other | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P) 0.2¢/kg + 3.1% (SG) | 15.4¢/kg + 52% |
2933.19.45 | 00 | Other: | | | | |
2933.19.70 | 00 | Other: | | | | |
2933.19.90 | 00 | Other | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 30.5% |
2933.21.00 | 00 | Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure: | | | | |
2933.29 | | Other: | | | | |
2933.29.20 | 00 | Other: | | | | |
2933.29.35 | 00 | Other: | | | | |
2933.29.43 | 00 | Other | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4¢/kg + 52% |
2933.29.45 | 00 | Other: | | | | |
2933.29.60 | 00 | Other: | | | | |
2933.29.90 | 00 | Other | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 30.5% |
2933.31.00 | 00 | Compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure: | | | | |
2933.32.50 | 00 | Other | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX,P) 2.9% (SG) | 15.4¢/kg + 52% |
2933.33.00 | 00 | Alfentanil (INN), anileridine (INN), bezitramide (INN), bromazepam (INN), difenoxin (INN), diphenoxylate (INN), dipipanone (INN), fentanyl (INN), ketobemidone (INN), methylphenidate (INN), pentazocine (INN), pethidine (INN), pethidine (INN) intermediate A, phencyclidine (INN) (PCP), phenoperidine (INN), pipradrol (INN), piritramide (INN), propiram (INN) and trimeperidine (INN); salts thereof | kg | Free | | 15.4¢/kg + 149.5% |
2933.39 | | Other: | | | | |